Publications

This comprehensive review explores the close mechanisms between gut anatomy, microbial ecology, and host regulatory mechanisms that maintain intestinal barrier integrity and systemic health. It highlights the specialized roles of epithelial cell types and junctional complexes in preserving selective permeability, emphasizing how disruptions from stress, aging, inflammation, and mitochondrial dysfunction contribute to increased intestinal permeability and dysbiosis. The metabolic and immunomodulatory functions of gut microbiota, particularly short-chain fatty acid production and bile acid transformation, are examined in relation to barrier maintenance and immune tolerance. The impact of microbial imbalance on gastrointestinal and extraintestinal diseases, including irritable bowel syndrome, inflammatory bowel disease, metabolic syndrome, and neurodegenerative disorders, is detailed alongside mechanisms linking barrier dysfunction to systemic inflammation and autoimmune processes. Diagnostic approaches utilizing serological, urinary, microbial, and proteomic biomarkers are discussed for assessing permeability and guiding clinical management. Therapeutic strategies encompass microbiota-targeted interventions such as fecal microbiota transplantation, synbiotic supplementation, nutritional modulation including zinc, selenium and specialized diets, regenerative techniques like stem cell and peptide therapies, and lifestyle modifications focusing on physical activity and sleep optimization. Neural and immune signalling pathways within the microbiota–gut–brain axis are elucidated, illustrating their roles in gastrointestinal function and mental health. Integrative models presented provide a framework for translating molecular and ecological insights into effective interventions aimed at restoring gut barrier function and systemic homeostasis.

Authors Bio:

Professor Dato’ Sri Dr. Mike K.S. Chan is a pioneer of cellular and cell membrane therapy in Europe and Asia since the early 1980s. He founded one of the world’s largest researchers of bio-molecular medicine based in Switzerland and Germany with a global presence in almost eighty countries. He has conducted more than 1,000 lectures, seminars, and symposiums worldwide in the fields of antiaging, cell regeneration, regenerative medicine, and stem-cell therapies.

Dr. Yuriy Nalapko, MD, PhD, is an academician and practical medical doctor in intensive care, antiaging, and bioregenerative medicine—an area of scientific interest in longevity and how a cell functions with different diseases. He is the author of many handbooks, monographs, and more than 300 articles. Based on his clinical experience, he proposed new approaches to reverse degenerative diseases of the brain, liver, and endocrine organs in different disorders. In metabolic disorder therapy, he combines preventive, pharmacological, and bioregenerative approaches as a state-of-the-art paradigm to correct structural and functional malfunctions.

For centuries, the placenta has been regarded as a transient organ—essential for life yet discarded at birth. Placenta Untold challenges this perception and reveals the placenta as a biologically sophisticated organ with immense therapeutic potential. This book explores the science behind the placenta’s remarkable functions: nutrient exchange, immune modulation, hormonal regulation, and cellular communication and moves beyond pregnancy to examine its applications in regenerative medicine. Drawing from historical traditions, modern biomedical research, and biotechnology, the authors highlight how placenta-derived extracts, stem cells, growth factors, and bioactive molecules are being applied in wound healing, cardiovascular and liver health, neuroprotection, immunomodulation, anti-aging medicine, and veterinary therapeutics. Each chapter connects core placental biology with clinical insight, covering proteomics, pharmacological mechanisms, bioethics, and product development. The book repositions the placenta from “medical waste” to a valuable and ethically acceptable source of regenerative biomaterials.

Who should read this book?

Medical doctors, regenerative medicine practitioners, researchers, biomedical scientists, pharmacologists, aesthetic professionals, and postgraduate life science students will find this book highly relevant. It also serves biotechnology innovators and those involved in stem cell and translational research.

Why read this book?

Readers will gain a strong scientific understanding of placental biology, evidence-based insight into therapeutic applications, awareness of regulatory and ethical considerations, and a forward-looking view of how placental science may shape the future of regenerative and personalized healthcare.

Authors' Bio:

Professor Dato’ Sri Dr. Mike K.S. Chan is a pioneer of Cellular and Cell Membrane Therapy in Europe and Asia since the early 1980’s. He founded one of the world’s largest researchers of Bio-Molecular Medicine based in Switzerland and Germany with a global presence in almost eighty countries. He has conducted more than 1,000 lectures, seminars, and symposiums worldwide in the fields of antiaging, cell regeneration, regenerative medicine, and stem-cell therapies.

Prof. Dato’ Sri Dr. Michelle B.F. Wong is a distinguished scientist, researcher, and educator, actively engaged in stem cell research and development (R&D), with a particular focus on fetal precursor stem cell therapy. For over three decades, she has served as Co-Founder, Senior Technical Advisor, and Researcher at FCTI Inc., a company specializing in stem cell research and bio-regenerative medicine. Her solid academic foundation in nutrition and naturopathy has facilitated a seamless transition into R&D within the field of stem cell bio-regenerative medicine. Dr. Wong is also a highly respected speaker, regularly delivering presentations at educational programs and international conferences on topics such as stem cells, cell therapy, and biological medicine-benefiting physicians and healthcare practitioners worldwide.

Dr. Patricia Pan is a Senior Researcher leading strategic research initiatives in immunology, medical biotechnology, and regenerative medicine. She holds a Ph.D. in Biotechnology, with expertise in immunomodulation, gene expression profiling, and biomedical research. She is actively engaged in the design and execution of preclinical studies, ensures compliance with international regulatory standards including ICH guidelines, and oversees the advancement of biological products toward Phase I clinical trials.
In addition to her research activities, she has extensive experience teaching the Medical Laboratory Technology (MLT) program, delivering courses in clinical microbiology, immunology and serology, immunohematology, and clinical parasitology. Dr. Patricia Pan remains committed to advancing evidence-based innovation and research in biomedical and regenerative sciences.

Football has become one of the most physically demanding, technologically advanced, and scientifically scrutinised sports in the modern era. Handbook of Football in Regenerative Sport Medicine: Injuries • Pain Management • Recovery • Performance • Endurance and Stamina • Rehabilitation • Regeneration • Longevity delivers a comprehensive and future-oriented exploration of the evolving landscape of football medicine, integrating elite performance science with emerging regenerative and longevity-based strategies.

Covering the realities of modern football from grassroots development to elite competition, this handbook examines the full spectrum of football-related injuries, including muscle injuries, ligament and tendon disorders, concussions, overuse syndromes, fatigue-related injuries, and return-to-play challenges. It further addresses contemporary approaches to pain management, rehabilitation, recovery optimisation, fixture congestion, travel fatigue, neurofatigue, load monitoring, nutrition, psychological readiness, and performance resilience within the high-pressure environment of modern football.

Bridging clinical practice with cutting-edge science, this handbook examines injury prevention, diagnosis, and rehabilitation alongside emerging advances in bioregenerative medicine, including stem cell–based therapies and novel tissue healing strategies such as mitochondrial peptides and exosome-based interventions. It further explores performance optimisation through load management, nutrition, neurocognitive function, and recovery strategies, while addressing the long-term objective of extending athletic career longevity within an increasingly congested and demanding competitive landscape.

Written for footballers, coaches, technical directors, clinicians, physiotherapists, sports scientists, researchers, and performance practitioners, this handbook reflects the realities of modern football, where athlete health, competitive performance, recovery, and long-term sustainability must be continuously balanced against escalating physical and commercial demands. Integrating sports medicine, regenerative medicine, rehabilitation science, neuroscience, and performance physiology, it provides a multidisciplinary framework for safeguarding athlete welfare while maximising performance across the lifespan.

Combining scientific rigor with practical application, this book stands as a definitive reference for the next generation of football medicine, regenerative athlete care, and high-performance longevity science.

Authors' Bio:

Professor Dato’ Sri Dr. Mike K.S. Chan is a pioneer of Cellular and Cell Membrane Therapy in Europe and Asia since the early 1980’s. He founded one of the world’s largest researchers of Bio-Molecular Medicine based in Switzerland and Germany with a global presence in almost eighty countries. He has conducted more than 1,000 lectures, seminars, and symposiums worldwide in the fields of antiaging, cell regeneration, regenerative medicine, and stem-cell therapies.

Dr. Glen Alvin is a seasoned medical professional in Dermatology, Aesthetic Medicine, and Regenerative Medicine, with many years of experience in stem cell therapy research. He holds an MD, an Advanced Diploma in Dermatology, and a Master’s in Aesthetic Medicine. Dr. Glen has made significant contributions to his field through numerous publications and lectures at international conferences. His research includes groundbreaking work on cell therapy in Dermatology and Aesthetic Medicine. His ambition is to secure cell therapy a place in mainstream medicine.

European Wellness researchers and collaborators have just published a compelling new study in the Journal of Stem Cell Research – exploring how the secretomes of organ-specific stem cells could potentially accelerate the healing of human blood vessel cells, without using the stem cells themselves.

Here's What It's About:

Stem cells don't heal only by replacing damaged tissue – they release a rich mix of growth factors, cytokines, and extracellular vesicles known as the "secretome." Using a Human Umbilical Vein Endothelial Cell (HUVEC) scratch assay, the team compared secretomes drawn from five different tissues – Retina, Kidney, Brain, Heart, and Thymus – to see how each influenced wound healing:

✅ Heart and Brain secretomes showed the strongest, most sustained effect – with treated cells reaching near-complete wound closure (~99%) by 48 hours

✅ Kidney secretome showed the fastest early response – with cell migration advancing ahead of the untreated control within the first 16 hours

✅ Every secretome outperformed the untreated control – and, unlike the control, appeared to maintain those gains over time rather than losing ground

💡 Why This Matters:

A cell-free approach could potentially offer many of the benefits of stem cell therapy with greater scalability, simpler handling, and possibly lower immune risk. These early in-vitro findings suggest the secretome may be a promising avenue for future research into vascular repair, wound healing, and tissue engineering – and offer an intriguing hint that different organs may carry their own distinct regenerative "signatures."

MORE PUBLICATIONS:
https://european-wellness.eu/publications/

Male infertility accounts for nearly half of all infertility cases worldwide - and sperm quality has been declining for decades. While conventional treatments often address symptoms, what if we could target the root causes at the molecular level?

European Wellness researchers and collaborators have just published a comprehensive new review exploring how bioactive peptides could potentially reshape the future of male reproductive medicine!

Here's what it covers:

The research team examines how peptide-based therapeutics work across multiple biological systems to address the complex, interconnected causes of male infertility:

✅ Mitochondrial peptides act as 'energy restorers' - boosting cellular ATP production and sperm motility by activating key pathways like PGC-1α, NRF1, and TFAM

✅ Endocrine-modulating peptides work as 'hormonal balancers' - supporting the body's own hormone production through the HPG axis rather than relying on external hormone replacement

✅ Organ-specific peptide complexes serve as 'precision regulators' - targeting gene expression in reproductive tissues to support steroidogenesis and tissue repair

✅ Nano-delivery systems are the 'smart carriers' - enhancing peptide stability, bioavailability, and targeted delivery to where they're needed most

Combined, these approaches offer a biologically integrated strategy that goes beyond treating symptoms to address the molecular drivers of infertility - from oxidative stress and mitochondrial dysfunction to inflammatory signalling and endocrine imbalance.

💡 Why this matters:

With global sperm counts declining by more than 50% over recent decades and environmental stressors on the rise, the need for next-generation fertility solutions has never been greater. This review lays the scientific groundwork for peptide therapeutics as a promising frontier in male reproductive medicine - one that works with the body's own regulatory systems to restore reproductive health from the inside out.

MORE PUBLICATIONS:
https://european-wellness.eu/publications/

About the Study:

Managing osteopenia in patients with nephrolithiasis presents a unique clinical challenge, as calcium supplementation may improve bone density while simultaneously increasing the risk of kidney stone recurrence.

This study evaluated the efficacy and safety of combined calcium citrate, vitamin D3, and vitamin K2 therapy in patients with osteopenia and nephrolithiasis, with a comprehensive assessment of:

✔️ Bone mineral density (BMD)
✔️ Trabecular bone quality (TBS)
✔️ Bone turnover markers
✔️ Renal salt transport parameters
✔️ Oxalate and calcium excretion profiles

🔬 Key Findings:

• Combined calcium citrate therapy improved lumbar spine BMD in both patient groups
• Significant reductions in urinary oxalate excretion were observed during treatment
• Patients with hypercalciuria required careful monitoring and benefited from thiazide diuretic substitution according to urological guidelines
• The study highlights the importance of personalized metabolic evaluation before initiating osteopenia treatment in patients with kidney stone disease

These findings contribute to a more precise and integrative strategy for managing patients with overlapping metabolic bone and renal disorders.

MORE PUBLICATIONS:
https://european-wellness.eu/publications/

This publication presents a compelling case demonstrating functional improvement in a patient with progressive cerebellar ataxia using an integrative regenerative medicine protocol.

Progressive multisystem cerebellar ataxia is a debilitating neurodegenerative disorder characterized by impaired coordination, balance disturbances, and progressive neurological decline. Conventional treatments often focus primarily on symptom management.

This case report explores a multimodal regenerative approach, integrating advanced therapeutic strategies aimed at supporting:

🧠 Neuroregeneration and neural repair
⚡ Cellular metabolism and mitochondrial function
🧬 Neuroprotective and anti-inflammatory mechanisms
🔄 Functional neurological recovery

The findings highlight the potential of integrative regenerative medicine frameworks to support neurological function and improve patient outcomes in conditions traditionally considered difficult to treat.

MORE PUBLICATIONS:
https://european-wellness.eu/publications/

Golf may look gentle, but for millions of players it quietly delivers a heavy—and often chronic—injury toll. Golf Players’ Injuries: BioRegenerative Sport Medicine & Holistic Perspectives reframes “nagging” golf pain as a predictable outcome of repetitive, asymmetrical swing mechanics, accumulated load, and incomplete tissue recovery. From low back pain and shoulder dysfunction to golfer’s elbow, wrist tendinopathies, hip and knee problems, this book maps the most common injury patterns across amateurs and professionals—and explains why they happen.

Blending sports medicine, biomechanics, and modern healing science, the authors move beyond symptom control to explore a biology-driven approach aimed at genuine tissue restoration. You’ll discover how kinetic-chain breakdowns contribute to specific injuries, how cellular and molecular repair can stall, and what emerging regenerative tools—such as precursor stem cell concepts, exosomes, nano-peptides, mitochondrial support, and advanced physiotherapy modalities—may offer when conventional care falls short.

Written for golfers, clinicians, and performance professionals, this is a practical, evidence-informed guide to understanding golf injuries, improving diagnosis, and supporting a safer, stronger return to play.

Prof. Dato’ Sri Dr. Mike K.S. Chan is Founder & Chairman of the European Wellness Biomedical Group and Chief Researcher/Chief Technical & Research Director across its international R&D programs. A pioneer of cellular therapy since the 1980s, he helped introduce stem cell and bioregenerative medicine across Asia, building a global network of clinics and research centers—today a chain of 40+ integrative and regenerative medical clinics with 1,000+ staff. He serves as ESAAM Scientific Committee Head for Regenerative Medicine & Stem Cells and ESAAM Chairman/Director for Asia; Associate Professor (AASCP, USA); Associate Professor (Lincoln University College, Kuala Lumpur); Chairman of the European Wellness Academy; Senator of Germany’s BWA; and Honorary Chief Healthcare Advisor to Swiss Strategic Partners. His portfolio includes multiple international patents in immunotherapy, stem cell transport media, and parenteral formulations, and he is a multi-award recipient in Europe and the Middle East. An active academic collaborator (MIT, Cambridge, USC, UCI, Heidelberg), Prof. Chan has authored/co-authored 60+ books and 150+ scientific publications, and has delivered 1000+ lectures and seminars across 60+ regions on anti-aging, regenerative medicine, peptides, and stem cell therapies.

Dr. Dina Tulina is a Medical Advisor and physician specializing in anti-aging, regenerative medicine, and comprehensive wellness. She integrates preventive, biological, and natural care to promote longevity and vitality beyond conventional practice. At European Wellness Global, she contributes to biomedical innovation with holistic approaches and the translation of research into practical applications. Guided by her belief that true health is balance and vitality, and functional longevity, Dr. Tulina is dedicated to shaping the future of personalized and preventive healthcare.

European Wellness researchers and collaborators have published a compelling new review in the American Journal of Biomedical Science & Research – exploring how mitochondrial dysfunction sits at the very heart of metabolic syndrome, and how targeted peptide therapies could help restore the body's metabolic engine from the inside out!

💡 Why this matters:

• Metabolic syndrome is one of the defining health challenges of our time, and conventional approaches often target symptoms one organ at a time.
• Rather than addressing isolated symptoms, this research points toward a holistic, hypothesis-driven model that targets the root cause - cellular energy failure.
• While more clinical trials are needed, the science points toward an exciting future where peptide-based therapies could help restore the body's natural metabolic flexibility and reduce cardiometabolic risk at its source.
• The paper explores two promising frontiers in peptide-based intervention: Mitochondrial-derived peptides and Multi-organ peptide constructs.

MORE PUBLICATIONS:
https://european-wellness.eu/publications/

About the Article:

Erectile dysfunction (ED) is a common male health condition with complex multifactorial causes, including vascular, neurological, endocrine, and psychosocial contributors. Traditional therapies like phosphodiesterase type 5 inhibitors remain first‑line, but they don’t fully address underlying tissue, nerve, or metabolic dysfunction.

This review presents a comprehensive management framework that blends conventional diagnostics and pharmacotherapy with emerging regenerative and integrative strategies, targeting the biological roots of ED and expanding therapeutic possibilities beyond symptom control.

Key Themes Covered:

✔️ Detailed overview of ED pathophysiology and clinical assessment
✔️ Conventional medical treatments and personalized management principles
✔️ Regenerative medicine approaches, including cell‑based and peptide‑based therapeutics
✔️ Lifestyle, metabolic, and psychosocial considerations in ED care
✔️ A future‑forward framework integrating traditional care with regenerative innovation

By uniting established evidence and next‑generation therapeutic concepts, this article highlights a holistic path forward for improving erectile function and overall male sexual health.

MORE PUBLICATIONS:
https://european-wellness.eu/publications/